Hypogonadism and Testosterone Use

    Basic Details
    Date Posted
    Wednesday, July 6, 2016
    Status
    Complete
    Medical Product
    testosterone
    Health Outcome(s)
    hypogonadism
    Description

    Modular program-based one-time assessment of testosterone use among hypogonadism cohorts. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2000 to May 31, 2013.  Modular programs are adaptable standardized programs. Results were generated using Modular Program 3; click here for more information.  Queries were distributed in August 2014. This report includes data from 17 Data Partners.
     
    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.
     
    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2000 to May 31, 2013
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All males
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)